Innovative Hybrid Compounds Targeting Tuberculosis: Development, Characterization and Bioefficacy analysis of 6-substituted-2-Chloroquinoline-3-Carbaldehyde Hydrazide Ester derivatives. Int. J. Pharm. Sci. Drug Res. [Internet]. 2024 May 30 [cited 2025 Oct. 15];16(3):378-86. Available from: https://ijpsdronline.com/index.php/journal/article/view/9307